Collaboration with academia to be reinforced

On 3 April 2017, the European Medicines Agency (EMA) announced that it intends to reinforce collaboration with academia.

In a press release the EMA announced that it developed a framework to formalise, structure and further develop interactions with the academic community in the context of the European medicines regulatory network.

The framework’s overall objectives are:

  • raising awareness of the mandate and work of the European medicines regulatory network to increase academia’s trust in and engagement with the regulatory system;
  • fostering the translation of academic research into novel methodologies and medicines which meet regulatory standards and address needs of public and animal health;
  • ensuring that the best scientific expertise and academic research are available on time to support effective evidence generation, regulatory advice and guidance, as well as decision-making in regulatory processes;
  • working with academia to develop regulatory science that embraces scientific progress in medicines development without compromising patient safety, such as for example, the use of novel endpoints or novel methodologies.

Further information can be found here


Date: 08/05/2017 | Tag: | News: 596 of 599
All news

News

More news

Events

More events
newsletter

Subscribe to the VPH Institute Newsletter

Are you...

A clinician?
A researcher?
A science curious?
An industrial?

Open subscribe

ARCHIVE

Read all the newsletters of the VPH Institute

GO